Product information and disease descriptionPlace of product in therapyDisease description
Definition and etiology
10 evidence topics · 10 sources
Clinical definition
“Rett syndrome (RTT) is a severe, progressive, neurodevelopmental disorder, which affects predominantly females. In most cases, RTT is associated with pathogenic variants in MECP2. MeCP2, the protein product of MECP2, is known to regulate gene expression and is highly expressed in the brain. RTT is characterized by developmental regression of spoken language and hand use that, with hand stereotypies and impaired ambulation, constitute the four core diagnostic features.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The clinical picture associated with typical RTT is defined by a regression of purposeful hand use and spoken language, with the development of gait abnormalities and hand stereotypies. After the period of regression, a stage of stabilization and potentially even improvement ensues, with some individuals partially regaining skills.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Sponsor description of the disease
Original descriptions by Rett and by Hagberg
“Rett Syndrome (RTT, MIM 312750), an X-linked neurodevelopmental condition characterized by loss of spoken language and hand use with the development of distinctive hand stereotypies, was originally described in the 1960’s by Andreas Rett” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Believing the symptoms to be consistent with a metabolic disorder, he called it ‘cerebroatrophic hyperammonaemia’ in a 1966 German publication” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Thirty-five patients, exclusively girls, from three countries had a uniform and striking progressive encephalopathy.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The condition is similar to a virtually overlooked syndrome described by Rett in the German literature.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Genetic cause: MECP2 variants
“Our study reports the first disease-causing mutations in RTT and points to abnormal epigenetic regulation as the mechanism underlying the pathogenesis of RTT.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Using a battery of modern mutation detection assays, mutations in MECP2 can be found in 95–97% of individuals with typical RTT” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Importantly, even using the best methodologies, 3–5% of individuals who strictly meet clinical criteria for RTT do not have an identified mutation in MECP2, indicating that a mutation in this gene is not required to make the diagnosis of typical RTT” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The situation is more dramatic in atypical cases, with only 50–70% having identified mutations in MECP2” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Because MECP2 mutations are neither necessary nor sufficient to make the diagnosis of RTT, RTT remains a clinical diagnosis.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
MECP2-related disorders nomenclature
De novo occurrence and X-linked inheritance
Paternal origin of de novo variants and female predominance
“RTT almost exclusively affects female offspring and, in 99.5% of all cases, is sporadic and due to de novo mutations in the MECP2 gene.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We analyzed the parental origin of MECP2 mutations in sporadic cases of RTT, by analysis of linkage between the mutation in the MECP2 gene and intronic polymorphisms in 27 families with 15 different mutations, and we found a high predominance of mutations of paternal origin in 26 of 27 cases (P<.001).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We conclude that de novo mutations in RTT occur almost exclusively on the paternally derived X chromosome and that this is most probably the cause for the high female:male ratio observed in patients with RTT.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Males with MECP2 variants
“To enhance understanding of the phenotypic spectrum present in these individuals, we identified thirty males with MECP2 mutations in the RTT Natural History Study databases. A wide phenotypic spectrum was observed, ranging from severe neonatal encephalopathy to cognitive impairment. Two males with a somatic mutation in MECP2 had classic RTT.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“careful review of the clinical history determined that an additional 12/28 subjects met criteria for atypical RTT, but with more severe clinical presentation and course, and less distinctive RTT features, than females with RTT, leading to the designation of a new diagnostic entity, Male RTT Encephalopathy.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote